YD

Yizhen Dong

Healthcare Investor & Builder; Family Office

United States

Invests in

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Work Experience

  • Healthcare & Life Sciences Growth Equity

    2022 - 2024

    Healthcare software and tech-enabled services Life sciences software, tools, services AI/ML in biotech and healthcare

2022 - 2024

  • Board Director

    2022 - 2024

    Led Series B and co-invested with Bessemer Venture Partners, Flare Capital, Takeda Ventures, CVS Ventures

2022 - 2024

  • Board Observer

    2022 - 2024

2022 - 2024

  • Board Observer

    2022 - 2024

    Led Series C and co-invested with Eclipse VC, Decheng Capital, and DFJ Growth

  • Co-Founder & Interim CEO

    2020 - 2024

    Co-founded startups in therapeutics and pharma services

  • Life Sciences & Healthcare Partner, VC & Growth Equity

    2020 - 2022

2016 - 2020

  • Principal, Life Sciences and Healthcare VC

    2016 - 2020

2016 - 2020

  • Board Observer

    2016 - 2020

2013 - 2014

  • Strategic Planning

    2013 - 2014

    Product launch Real world evidence Commercial strategies Market research, forecasting

2011 - 2014

  • Management Consultant

    2011 - 2014

    Real World Evidence (RWE) analytics Biotech M&A transactions Market Research